Tiwari, seniormost GMC doctor, named new dean
Dr Jai Prakash Tiwari
, professor of nephrology, was appointed as the new Dean of Goa Medical College and Hospital (GMC) by the govt on Tuesday. Dr Shivanand Bandekar retired as the Dean on Monday.
For the last four years, the govt did not appoint Tiwari as GMC dean despite him being the most senior doctor at GMC as per the seniority list. This is the second time the govt has issued an order to appoint Tiwari as dean.
Tiwari joined GMC in 1995 and became a professor in 2001. He was instrumental in setting up the dialysis and kidney transplant facility for the first time at the state's premier hospital.tnn
.
He was also instrumental in starting a specialised course called DM Nephrology, which is offered in a few govt-run medical colleges.
Since 2021, the Goa Public Service Commission (GPSC) has been recommending Tiwari's name for the top post at GMC. In 2022, the personnel department under chief minister Pramod Sawant issued an order to appoint Tiwari as dean, but a few hours later, health minister Vishwajit Rane requested Sawant to keep the order in abeyance.
Bandekar was appointed dean in February 2019 after former Dean Dr Pradeep Naik was asked to report to the office of the public health department. Earlier, the state govt rejected the recommendation of the GPSC.
Get the latest lifestyle updates on Times of India, along with
Doctor's Day 2025
,
messages
and quotes!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
17 hours ago
- Indian Express
Maharashtra medical admissions: first round of seat allotment announced for UG courses
The Maharashtra Common Entrance Test (CET) Cell seat allotment results for the first round of centralised medical admissions for undergraduate (UG) courses for the state quota seats witnessed a significant drop in cut-off scores for MBBS admissions in both government and private medical colleges. In government medical colleges, the cut-off score for MBBS admissions has fallen to 509 marks, down from 642 marks in the first round last year. In private medical colleges, the cut-off has dropped to 479, against 602 marks in 2024. Candidates, however, highlighted that this was an anticipated drop in the cut-off score due to the overall lower National Eligibility cum Entrance Test (NEET) for Undergraduate (UG) scores this year — unlike the inflated scoring patterns observed last year. One candidate pointed out that there was score inflation in NEET UG last year due to a combination of factors. 'Unlike last year, when many students scored unusually high marks, this year's NEET UG results showed significantly lower scores. So, a drop in cut-off was expected. But this drop is still quite significant,' the candidate said. However, a parent representative Sudha Shenoy pointed out that this is a very low cut-off score in the past few years, especially in government medical colleges (GMC). 'Generally, private medical colleges would have a cut-off score around 509 for the first round of seat allotment. But this year, the same score is enough for a GMC seat in the first round,' said Shenoy. She attributed the change to a more streamlined admission process without any pending approvals for colleges or seats, this year. 'Last year there was chaos due to pending approvals for seats, despite inclusion of those seats in the seat matrix,' she said. As per the seat allotment for the first round of medical UG admissions by the Maharashtra CET Cell, a total of 10,815 candidates were allotted seats in this round, including 8,106 for MBBS and 2,709 for BDS. Students have until August 22 to confirm admission on their allotted seats. The total number of UG medical seats under the state quota stands at 10,856, comprising 8,138 MBBS seats and 2,718 BDS seats.
Time of India
19 hours ago
- Time of India
14 acute diarrhoeal disease cases at Cutbona jetty, 1 worker gets cholera
Panaji: Fourteen fish trawler workers at the Cutbona jetty were diagnosed with the acute diarrhoeal disease, of which one was confirmed to be cholera. Around 1,600 trawler workers who have migrated to Goa for the fishing season were screened for cholera, dengue, and malaria. Tired of too many ads? go ad free now The health department is considering the latest episode a possible outbreak of the acute diarrhoeal disease. The 14 cases were detected over a ten-day period beginning Aug 4. Most workers are said to have migrated to Goa from Odisha and Chhattisgarh. One of the workers admitted to GMC has been discharged. The rest are said to be undergoing domiciliary treatment and monitored by the Bali health centre. At an inspection of the jetty on Thursday, garbage was found, and directions were issued to the panchayat to remove it. After stagnant water was found in dinghies at the jetty, directions were issued to the directorate of fisheries to clear it. The directorate of health services prepared packets of paracetamol, antibiotics, and ORS and distributed them to fish trawler owners. The packets are to be given to workers who fall ill while at sea. The fishing season draws 3,000-4,000 workers to the jetty. 'There must be no open defecation, and hands must be washed thoroughly. Drinking water must be clean and boiled, and food must be hygienic,' said state epidemiologist Dr Utkarsh Betodkar. Last year saw five trawler workers die due to cholera, with some declared brought dead.
Economic Times
a day ago
- Economic Times
Goa becomes India's first state to cut prices on high-cost cancer and rare disease therapies
Synopsis Goa government introduces a pioneering pricing policy for expensive treatments, including cancer and rare diseases, making it the first state in India to do so. This initiative allows the state to negotiate prices for drugs, medical equipment, and diagnostics, ensuring more patients can access critical care. ETHealthWorld In a bid to make life-saving therapies more accessible to patients, the Goa government has introduced a groundbreaking pricing policy for expensive treatments, including those for cancer and rare diseases, according to a TOI report. The initiative allows the state to procure drugs, medical equipment, and diagnostics at negotiated prices below the listed rates, enabling resources to reach a larger number of patients or extend the duration of therapies. Health Minister Vishwajit Rane announced on Wednesday that Goa is the first state in the country to implement such a policy framework, which facilitates confidential pricing agreements with pharmaceutical companies and medical device manufacturers. The rollout is expected to begin with treatments for lung cancer, a condition among several high-cost therapies that can exceed Rs 50 lakh per year. According to Rane, this initiative represents a significant step toward health equity, ensuring more patients can access critical care. 'Goa's adoption of this value-based pricing policy is both timely and essential,' Rane said. 'It will improve access to innovative therapies and help more patients benefit from these treatments.' Addressing the rising burden of diseases The report noted that Goa faces a growing healthcare challenge, with around 1,500 new cancer cases diagnosed annually, expected to rise by 5% each year. Breast cancer is the most common, accounting for over 300 cases, followed by oral cavity cancer, which makes up 20-25% of total cases. Rane highlighted the need for a more robust healthcare system to meet the increasing demand for specialized treatments and rare disease management. Policy framework & implementation The new pricing policy focuses on proprietary drugs and equipment already procured by the Goa Medical College (GMC) and the Directorate of Health Services (DHS) through standard tenders. If new patented drugs or devices are required, a committee will review the recommendation and seek approval from the finance department before inclusion. A committee led by the Additional/Joint Secretary of Health, along with the GMC dean, DHS director, and pharmacy heads, will determine appropriate pricing and negotiate with companies to secure the best rates for patented treatments. Once approved, the finalized list of drugs and equipment will be notified with finance department approval, TOI further reported. This move is expected to ease financial pressure on patients while equipping Goa's healthcare system to better handle the rising incidence of cancer and rare disorders, setting a precedent for other states to follow.
